CUSIP: 576810105
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,715,189
-
Share change
-
-2,925,135
-
Total reported value
-
$29,223,858
-
Price per share
-
$0.78
-
Number of holders
-
62
-
Value change
-
-$4,042,320
-
Number of buys
-
21
-
Number of sells
-
35
Quarterly Holders Quick Answers
What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2021
-
Previous quarter:
Q1 2021
Recent filing periods for CUSIP 576810105:
Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q2 2021
As of 30 Jun 2021,
MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,715,189 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., Sargent Investment Group, LLC, GSA CAPITAL PARTNERS LLP, COURAGE CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VICTORY CAPITAL MANAGEMENT INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and JTC Employer Solutions Trusteee Ltd.
This page lists
62
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.